TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Nattopharma AS
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
17,350
|
21,669
|
20,396 |
| Financial expenses |
-14,110
|
97
|
-1,964 |
| Earnings before taxes |
14,600
|
-1,158
|
4,190 |
| Total assets |
26,092
|
22,960
|
24,316 |
| Current assets |
19,149
|
12,867
|
11,935 |
| Current liabilities |
17,036
|
7,503
|
6,313 |
| Equity capital |
8,777
|
14,488
|
17,300 |
| - share capital |
5,995
|
6,328
|
5,661 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
33.6%
|
63.1%
|
71.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
84.1%
|
-5.3%
|
20.5% |
| Return on assets (ROA) |
1.9%
|
-4.6%
|
9.2% |
| Current ratio |
112.4%
|
171.5%
|
189.1% |
| Return on equity (ROE) |
166.3%
|
-8.0%
|
24.2% |
| Change turnover |
-3,181
|
165
|
7,924 |
| Change turnover % |
-15%
|
1%
|
64% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.